COMMUNIQUÉS West-GlobeNewswire

Retrophin Announces Topline Results from Phase 3 FORT Study of Fosmetpantotenate in Patients with PKAN
22/08/2019
FORT Study did not achieve its primary or secondary endpoints Company to host conference call and webcast today at 8:30 a.m. ET SAN DIEGO, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced [...]
So-Young to Report Second Quarter 2019 Financial Results on August 29, 2019
22/08/2019
BEIJING, Aug. 22, 2019 (GLOBE NEWSWIRE) -- So-Young International Inc. (NASDAQ: SY) (“So-Young” or the “Company”), the most popular online destination for discovering, evaluating and reserving medical aesthetic services [...]
Philips signs agreement to create Taiwan’s first fully digitalized pathology department
22/08/2019
August 22, 2019 Philips IntelliSite Pathology Solution adopted by Taiwan’s leading academic medical and teaching center Taipei Veterans General Hospital Philips IntelliSite Pathology Solution cleared for routine primary [...]
JSC Olainfarm refinances its liabilities and receives financing for development projects
22/08/2019
JSC Olainfarm and financial partner the bank BlueOrange have agreed to refinance existing liabilities on improved terms, provide additional financing for the company's development projects and planned investment in [...]
Ambu A/S: Interim report for Q3 2018/19
22/08/2019
In Q3, Ambu has achieved solid organic growth of 10% and an EBIT margin before special items of 20.1%. The pipeline has been advanced, US approval of ENT scopes secured, and Ambu is on plan for future launch of the [...]
Arcoma AB: Kraftfull resultatförbättring och ökad omsättning
22/08/2019
FI NANS I ELLT SAMMANDRAG Andra kvartalet Nettoomsättning för kvartalet ökade med 10% till 33 879 (30 888) kSEK. EBITDA (rörelseresultat före avskrivningar) steg med 52% till 3 470 (2 277) kSEK Resultat efter skatt [...]
Bone Therapeutics SA to report half year 2019 results on 30 August 2019
22/08/2019
Press Release Gosselies, Belgium, 22 August 2019, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the leading biotech company focused on the development of innovative cell and biological therapies to [...]
Bone Therapeutics SA publiera ses résultats du premier semestre 2019 le 30 août 2019
22/08/2019
Communiqué de presse Gosselies, Belgique, le 22 août 2019, 07h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de biotechnologie spécialisée dans le développement de thérapies cellulaires [...]
Genmab Announces Approval of DARZALEX® (daratumumab) in Frontline Multiple Myeloma in Japan
22/08/2019
Company Announcement DARZALEX ® approved in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple myeloma ineligible for autologous stem cell transplant in [...]
IBA Reports Half Year Results for 2019
22/08/2019
Group revenue up 13.8% to EUR 102.8 million, with higher revenues expected over H2 2019 Market leadership confirmed in all business lines and major geographies Two Proteus ® ONE solutions sold in Italy and USA Contract [...]
IBA annonce ses résultats du premier semestre 2019
22/08/2019
Hausse des revenus du groupe à hauteur de 13,8% pour atteindre EUR 102,8 millions, avec des revenus supérieurs attendus au second semestre 2019 Position de leader confirmée sur le marché, tous secteurs d’activité [...]
Interim Report Q2 2019: Strong performance across the group with 16% organic revenue growth in Q2. Guidance upgraded for GN Audio
22/08/2019
GN delivered 16% organic revenue growth in Q2 2019. Revenue growth was 19% including around 3% impact from the development in foreign exchange rates EBITA increased 16% compared to Q2 2018 driven by strong operational [...]
Devonian Announces the Closing of a $315,000 Private Placement and an Additional Loan of $500,000
22/08/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES QUEBEC CITY, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) (TSXV: GSD) is [...]
Devonian complète un placement privé de 315 000 $ et obtient un prêt additionnel de 500 000 $
22/08/2019
NE PAS DISTRIBUER AUX AGENCES DE PRESSE AMÉRICAINES NI DIFFUSER AUX ÉTATS-UNIS QUÉBEC, 21 août 2019 (GLOBE NEWSWIRE) -- Groupe Santé Devonian Inc. (« Devonian » ou la « Société ») (TSXV: GSD) a le plaisir d’annoncer qu’ [...]
Avinger Prices $4.5 Million Underwritten Public Offering of Common Stock
22/08/2019
REDWOOD CITY, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced the pricing of an underwritten [...]
Ambu A/S: Ambu invests into a 100% direct sales organisation for pulmonology in the US
22/08/2019
Ambu has decided to invest further and strengthen its largest market by transitioning sales of aScope™ products from the US distributor. As a result, Ambu will move to a 100% direct sales organisation for pulmonary [...]
Genmab Announces Preliminary Data to be Presented at IASLC 2019 World Conference on Lung Cancer
21/08/2019
Media Release Copenhagen, Denmark, August 21, 2019 Genmab A/S (Nasdaq: GMAB) announced today that preliminary data from the Phase I/II trial of enapotamab vedotin in advanced non-small cell lung cancer (NSCLC) has been [...]
Golden Leaf Holdings Removed from Defaulting Issuer List
21/08/2019
TORONTO, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis company built around recognized brands for the wellness and recreational markets [...]
Novelion Therapeutics Announces Issuance of General Cease Trade Order in Canada and Notice of Delisting from Nasdaq
21/08/2019
VANCOUVER, British Columbia and CAMBRIDGE, Mass., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN) (“Novelion” or the “Company”) announced that, further to its press release dated August 12, [...]

Pages